Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Bennet

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of Diabetes and Its Complications|August 14, 2021
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocolJohan Sundström, Robin Kristófi, Ollie Östlund, et al.
European Journal of Public Health|April 17, 2025
Barriers and motivators associated with COVID-19 vaccination-a vaccine acceptance scoring system based on a population survey in southern SwedenAdam Mitchell, Mariam Hassan, Fredrik Kahn, et al.
BMC Medical Education|November 15, 2024
New pedagogical tools for vaccine education: preparing future healthcare workers for the next pandemicSylvain Gautier, Mia-Marie Hammarlin, Edit Paulik, et al.
Diabetes, Obesity & Metabolism|November 28, 2025
SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complicationsJan W Eriksson, Giovanni Fanni, Martin H Lundqvist, et al.
The Lancet Regional Health. Europe|June 26, 2023
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational studyLinnea Vikström, Peter Fjällström, Yong-Dae Gwon, et al.
Eclinicalmedicine|May 4, 2026
Weight trajectories and obesity onset between 17 and 60 years of age, and cause-specific mortality: the Obesity and Disease Development Sweden (ODDS) pooled cohort studyHuyen T Le, Marisa da Silva, Louise Bennet, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of Diabetes and Its Complications|August 14, 2021
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocolJohan Sundström, Robin Kristófi, Ollie Östlund, et al.
European Journal of Public Health|April 17, 2025
Barriers and motivators associated with COVID-19 vaccination-a vaccine acceptance scoring system based on a population survey in southern SwedenAdam Mitchell, Mariam Hassan, Fredrik Kahn, et al.
BMC Medical Education|November 15, 2024
New pedagogical tools for vaccine education: preparing future healthcare workers for the next pandemicSylvain Gautier, Mia-Marie Hammarlin, Edit Paulik, et al.
Diabetes, Obesity & Metabolism|November 28, 2025
SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complicationsJan W Eriksson, Giovanni Fanni, Martin H Lundqvist, et al.
The Lancet Regional Health. Europe|June 26, 2023
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational studyLinnea Vikström, Peter Fjällström, Yong-Dae Gwon, et al.
Eclinicalmedicine|May 4, 2026
Weight trajectories and obesity onset between 17 and 60 years of age, and cause-specific mortality: the Obesity and Disease Development Sweden (ODDS) pooled cohort studyHuyen T Le, Marisa da Silva, Louise Bennet, et al.
Pageof 8